Table 2.
Risk of asthma or recurrent wheeze (asthma/recurrent wheeze) in the offspring’s first three years of life by parental asthma diagnosis, maternal asthma and maternal asthma control status in Vitamin D Antenatal Asthma Reduction Trial (VDAART) adjusted for potential confounders using stepwise regression models
| Univariable analysis | Multivariable analysis Main variable: maternal and paternal asthma diagnosis status | Multivariable analysis Main variable: maternal asthma and control status | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | HR | 95% CI | P-value | Adjusted HR | 95% CI | P-value | Adjusted HR | 95% CI | P-value |
|
Parental asthma diagnosis Both non-asthmatics Paternal asthma but no maternal asthma Maternal asthma but no paternal asthma Both asthmatics |
1(Ref) 1.03 1.84 1.95 |
0.67–1.59 1.36–2.49 1.20–3.16 |
0.90 <0.001 0.008 |
1(Ref) 0.90 1.70 2.30 |
0.51–149 1.17–2.40 1.35–3.84 |
0.62 0.006 0.003 |
Not included | ----- | ----- |
|
Maternal asthma status Non-asthmatics Asthmatics with controlled asthma Asthmatics with uncontrolled asthma (at least one episode during pregnancy) |
1(Ref) 1.55 2.80 |
1.14–2.1 1.98–3.99 |
<0.001 <0.001 |
Not included | ----- | ----- |
1 (Ref) 1.70 2.40 |
---- 1.17–2.40 1.50–3.50 |
------ 0.005 <0.001 |
| Maternal age | 0.95 | 0.93–0.97 | <0.001 | ----- | ----- | ----- | ------ | ------ | ------ |
| Gestational age at delivery ≥37 weeks vs <37 weeks | 0.41 | 0.29–0.59 | <0.001 | 0.43 | 0.26–0.71 | 0.002 | 0.44 | 0.26–0.73 | 0.002 |
| Trial arm Placebo vs vitamin D intervention | 1.31 | 1.00–1.71 | 0.0515 | ----- | ----- | ----- | |||
|
Cord blood Vitamin D (ng/mL) Sufficient vs. insufficient (≥30 vs <30) |
0.61 |
0.44–0.83 |
0.002 |
0.66 |
0.47–0.90 |
0.012 |
0.67 |
0.49–0.92 |
0.012 |
|
Offspring Sex Male vs. Female |
1.64 |
1.25–2.16 |
<0.001 |
1.72 |
1.24–2.40 |
0.009 |
1.76 |
1.27–2.45 |
0.001 |
| Clinical site Boston San Diego St. Louis |
1(Ref) 0.52 0.98 |
0.37–0.75 0.72–1.33 |
<0.001 0.91 |
------ | ------ | ----- | ----- | ----- | ----- |
| Race White African American Other |
1(Ref) 1.59 0.82 |
1.19–2.13 0.53–1.29 |
0.002 0.39 |
------ | ------ | ------ | ----- | ----- | ----- |
| Maternal marital status Married vs. Unmarried or Divorced) |
0.54 |
0.40–0.71 |
<0.001 |
0.60 |
0.40–0.82 |
0.002 |
0.62 |
0.44–0.87 |
0.006 |
| Parity 1 vs ≥ 2 |
1.05 |
0.8–1.4 |
0.72 |
---- | ----- | ----- | ----- | ----- | ----- |
| Maternal education College and above vs. less than College |
0.64 |
0.47–0.86 |
0.004 |
----- | ----- | ----- | ----- | ----- | ----- |
| Body mass index at first appointment BMI≥25 vs. BMI<25 kg/m2 |
1.13 |
0.84–1.5 |
0.42 |
----- | ----- | ----- | ------ | ------ | ------ |
| Maternal eczema history Yes vs. no |
1.10 |
0.83–1.46 |
0.50 |
----- | ----- | ----- | ----- | ----- | ----- |
Abbreviation: HR, hazard ratio. Hazard ratios for the outcome were estimated using a Weibull model; HRs and CIs are 2 sided.